⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2208713 | 1.00 | — | — | |
| SCHEMBL3333794 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4189693 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL30218172 | 0.97 | — | — | |
| SCHEMBL3257979 | 0.92 | — | — | |
| SCHEMBL17135433 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL14893864 | 0.90 | — | — | |
| SCHEMBL22034671 | 0.85 | — | — | |
| SCHEMBL22034584 | 0.85 | — | — | |
| SCHEMBL2479084 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111978448-B | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2021-04-13 | — | — | CN | claimed |
| CN-111978448-A | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2020-11-24 | — | — | CN | claimed |
| CN-111978448-B | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2021-04-13 | — | — | CN | disclosed |
| CN-111978448-B | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2021-04-13 | — | — | CN | disclosed |
| CN-111978448-B | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2021-04-13 | — | — | CN | disclosed |
| CN-111978448-A | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2020-11-24 | — | — | CN | disclosed |
| CN-111978448-A | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2020-11-24 | — | — | CN | disclosed |
| CN-111978448-A | Ureido-modified (S) -2-ethynylpyrrolidine and preparation method and application thereof | 北京大学 | 2020-11-24 | — | — | CN | disclosed |
| EP-2018385-B1 | THIAZOLYL-DIHYDROQUINAZOLINES | BOEHRINGER INGELHEIM INT (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-8334378-B2 | Thiazolyl-dihydro-quinazoline compounds and processes for preparing same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-12-18 | — | — | US | disclosed |
| US-20100145041-A1 | Thiazolyl-dihydro-quinazoline compounds and processes for preparing same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-06-10 | — | — | US | disclosed |
| US-7691868-B2 | N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-06 | — | — | US | disclosed |
| US-20090047244-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS I | IDENIX PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090047244-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS I | IDENIX PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2009014730-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| EP-2018385-A1 | THIAZOLYL-DIHYDROQUINAZOLINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-01-28 | — | — | EP | disclosed |
| WO-2007115929-A1 | THIAZOLYL-DIHYDROQUINAZOLINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-10-18 | — | — | WO | disclosed |
| US-20070244104-A1 | THIAZOLYL-DIHYDRO-QUINAZOLINE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-10-18 | — | — | US | disclosed |